Read the full story by clicking on this headline.. |
Safety data for Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine in pregnant women was "generally favorable," the U.S. Food and Drug Administration staff reviewers said on Tuesday. The drugmaker is seeking approval for use of the shot in pregnant women to... |
0 Comments
Leave a Reply. |
NewsMaxA conservative American news and opinion website founded by Christopher Ruddy in 1998 & operated by Newsmax Media. Archives
June 2023
Categories |